Senior insider sale
Chief Scientific Officer at CONTINEUM THERAPEUTICS, INC. — senior position signals high conviction
$598.0K
41.34K shares
What this filing means
LORRAIN DANIEL S. plans to sell 41.34K shares of CONTINEUM THERAPEUTICS, INC. valued at approximately $598.0K. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 6/30/2026ACC: 0001950047-26-006667
Officer· Chief Scientific Officer
Since Mar 2026
41.34K
Shares to sell
$598.0K
Approx. market value
28.83K
Acquired (3 months)
1
Planned
3 completed
Securities Acquired — Last 3 Months1
Exercise of Stock Options
Cash
6/30/2026
28.83KTotal acquired28.83K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
6/30/2026 | Exercise of Stock Options Cash | 28.83K | — |
| Total | 28.83K | ||
Planned & Completed Dispositions4
Completed
—Completed
Units to sell
4.17K
Market value
$54.9K
6/1/2026
—Completed
Units to sell
4.17K
Market value
$54.7K
5/1/2026
—Completed
Units to sell
4.17K
Market value
$56.0K
4/6/2026
Planned — Approximate Date
NASDAQPlanned
Units to sell
28.83K
Market value
$432.4K
6/30/2026
Total
Units
41.34K
Value
$598.0K
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
| Completed | ||||
6/1/2026 | 4.17K | $54.9K | — | Completed |
5/1/2026 | 4.17K | $54.7K | — | Completed |
4/6/2026 | 4.17K | $56.0K | — | Completed |
| Planned — Approximate Date | ||||
6/30/2026 | 28.83K | $432.4K | NASDAQ | Planned |
| Total | 41.34K | $598.0K | ||